Answers are grounded in this paper and cite their sources.
Highlights the utility of exercise pulmonary haemodynamic testing in systemic sclerosis, indicating its potential prognostic value for early vascular disease detection.
Pulmonary arterial hypertension (PAH) is a leading cause of morbidity and mortality in systemic sclerosis (SSc) [1], and patients have a ∼10% lifetime risk of developing this devastating complication [2]. Despite targeted PAH therapy, outcomes of SSc-associated PAH (SSc-PAH) remain unsatisfactory, with a median survival of only 3–4 years from time of diagnosis [3, 4]. In the hope of further improving outcomes in SSc-PAH, early disease detection has been a major focus of research in the past decade [5–9]. One important and highly debated topic is the utility of exercise pulmonary haemodynamic testing for the early diagnosis of pulmonary vascular disease [10–12]. Exercise pulmonary hypertension may have prognostic significance in patients with systemic sclerosis
No takes yet. Share an insight, caveat, or question.
Lau et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: